| abstract |
This invention relates to novel substituted estratrien derivatives of gen eral formula (I) useful in therapy, especially for use in the treatment and/ or prevention of a steroid hormone dependent disorder requiring the inhibiti on of a 17.beta.-hydroxysteroid dehydrogenase (17- HSD) type 1, type 2 and/or type 3 enzyme, as well as to their salts, to pharmaceutical preparations c ontaining these compounds and to processes for the preparation of these comp ounds. |